Life-changing ideas become reality right here. We bring together the brightest minds from the worlds of business, research, education and healthcare delivery to answer some of the biggest health challenges facing Europe.Watch our story
Europe faces a turning point in health. An ageing population, the rising burden of chronic disease, and growing multi-morbidity are all placing pressure on health systems across Europe.
Our vast community, including approximately 150 world-class partner organisations, works across borders to connect the three worlds of business, research and education. We call this meeting point the ‘knowledge triangle’ because it’s where life-changing innovation happens.Find out more
Our ambition is to enable people in Europe to live longer, healthier lives. Our work goes beyond conventional approaches to disease management and disease prevention. We are building and growing businesses to create products and services that progress healthcare in Europe, while strengthening our economy.
What we do
We create an environment where the brightest minds can explore new ideas and find the practical resources to create products and services rooted in innovation. We’re activating a network of trail-blazers to break down barriers, challenge convention and put healthcare solutions in people’s hands.
WE STRIVE FOR
We match innovators with a task force of experts to develop commercially-viable products and services with the greatest potential for societal and economic impact in Europe.Find out more
Our Accelerator promotes business growth at every stage, from fledgling to mature – to shorten the time-to-market for the most promising start-ups.Find out more
WE BELIEVE IN
Our education activities inject innovation into learning to upskill professionals, provide students with new opportunities and encourage patients and citizens to live healthier lives.Find out more
graduates and professionals trained
products and services launched
News and Views
Read the latest news and opinions from thought-leaders in healthcare.
EIT Health-supported start-up raises $10m
Oxford Endovascular's successful funding round
Peptomyc start human trials of ‘universal cancer therapy’
First-in-human trial approved for novel Myc inhibitor
EIT Health and BioMed Alliance join forces
Signing Memorandum of Understanding (MoU) for two years